NCT04786600 2025-07-01A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 TrialUniversity of FloridaPhase 2 Terminated6 enrolled 11 charts